Research profile
Publications:
Patel K, Lambiase PD. 2014. The subcutaneous ICD – current evidence and challenges. Cardiovascular Diagnosis and Therapy. 4(6):449-459.
Patel K, Goldsmith DJA. 2014. Uric acid as a cardiorenal risk factor – ready for prime time? International Journal of Clinical Practice. 68(7):796-801.
Srinivasan N, Patel K, Qamar K, Taylor A, Baca M, Providencia R, Lambiase P, Tome-Esteban M, Elliot P. 2017. Disease severity and exercise testing reduce S-ICD left sternal ECG screening success in hypertrophic cardiomyopathy. Circulation: arrhythmia and electrophysiology. 10(4)
Providencia R, Elliot P, Patel K, McCready J, Babu G, Srinivasan N, Bronis K, Papageorgiou N, Chow A, Lowe M, Segal O, Lambiase P. 2016. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis. Heart. 0:1-11.
Stack BC Jr, Goldsmith DJA, Patel K. 2015. Secondary hyperparathyroidism. BMJ Best Practice. 16 February 2015. http://preview.bestpractice-bmj-com.external.bmjgroup.com/best-practice/monograph/1107/basics/definition.html
Creta A, Chow AW, Sporton S, Finlay M, Papageorgiou N, Honarbakhsh S, Dhillon G, Graham A, Patel K, Dhinoja M, Earley MJ, Hunter RJ, Lowe M, Rowland E, Segal OR, Calabrese V, Ricciardi D, Lambiase PD, Schilling RJ, Providência R. 2018. Catheter ablation for fascicular ventricular tachycardia: A systematic review. International Journal of Cardiology.
Barra S, Providencia R,Duekmke R, Boveda S, Marijon E, Reitan C, Borgquist R, Klug D, Defaye P, Sadoul N, Deharo J, Sadien I, Patel K, Looi K, Begley D, Chow A, LE Heuzey J, Sharad A. 2016. Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in heart failure patients. Heart.
Lockie TPE, Rolandi MC, Guilcher A, Perera D, deSilva K, Williams R, Asrress K, Patel K, Plein S, Chowienczyk P, Siebes M, Redwood SR, Marber MS. 2012. Synergistic adaptations to exercise in the systemic and coronary circulations that underlie the warm-up angina phenomenon. Circulation. 126(22):2565-74.
Patel K, MacRae CA. 2013. In vivo screening of p38 MAPK/MEK inhibitors in zebrafish to determine their effects on cardiovascular development and function. Cambridge Medicine Journal. March 18. (Abstract)
Presentations:
Patel K, Srinivasan N, Lambiase P. 2015. European Heart Rhythm Association Europace Cardiostim conference. Eligibility of hypertrophic cardiomyopathy patients for subcutaneous ICD: results of postural and exercise ECG screening. June 21. Milan, Italy. (Oral)
Patel K, Brennan C, Srinivasan N. 2015 British Cardiovascular Society Annual Conference. Assessing the efficacy of a nurse-led cardioversion service on clinical outcomes. June 9. Manchester, UK. (Poster)
Patel K, Tyson L, Mann S. 2015. Falk Symposium 197: autoimmune diseases of the liver. Attitude to and practice of diagnostic paracentesis on the general medical take: room for improvement? May 8. Lisbon, Portugal. (Poster)
Patel K. 2014. UCL Division of Medicine Innovation Award. How many patients with hypertrophic cardiomyopathy meet the criteria for S-ICD implant? December 18. London, UK. (Oral)
Patel K. 2013. London Cardiovascular Society Young Investigator Award (finalist). In vivo screening of p38 MAPK/MEK inhibitors in zebrafish to determine their effects on cardiovascular development and function. February 19. London, UK. (Oral)
Patel K, MacRae CA. 2013. National Student Association for Medical Research National Annual Conference. In vivo screening of p38 MAPK/MEK inhibitors in zebrafish to determine their effects on cardiovascular development and function. March 23. Edinburgh, UK. (Poster)
Atif M, Evans K, Hill M, Keen H, Monsell A, Patel K, Phung A, Stredder O (co-authors). 2012. International Congress of the Royal College of Psychiatrists. Teaching to learn – learning to teach: the role of peer teaching in the personal development of medical students. July 12. Liverpool, UK. (Poster)
Patel K. 2012. King’s College London Open Medical Education Committee. An assessment of central haemodynamic variables during serial exercise tests in patients with stable angina pectoris. March 21. London, UK. (Poster)